Compound ID | 1864
Synonym(s): S-4661
Class: Beta-lactam (carbapenem)
| Spectrum of activity: | Gram-positive & Gram-negative | 
| Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Carbapenems bind to all PBPs, with PBP2 and PBP4 as the highest-affinity targets.Carbapenems have a very broad spectrum incl. non-fermenters and are not hydrolysed by most beta-lactamases with exception of carbapenemases | 
| Description: | Semisynthetic, derived from thienamycin. Similar to meropenem | 
| Institute where first reported: | Shionogi Inc | 
| Year first mentioned: | 2003 | 
| Highest developmental phase: | Approved by FDA in 2007 | 
| Development status: | Discontinued | 
| Reason Dropped: | In treating patients with pneumoniae, doripenem showed increased risk of death and lower clinical cure rates compared to imipenem and cilastatin for injection | 
| Chemical structure(s): | |||||||||||
                               
  | 
                                               
                                               
                                               
                                               
                           
                           
                               
  | 
                                       
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/73303 | 
| Guide to Pharmacology: | doripenem | 
| Citations: | 
                                        
                                            
                                                
                                                
                                                     |